Request for Emergency Use Authorization of Niyadâ„¢ submitted to the FDA in April
Divestment of DSUVIA® to Alora Pharmaceuticals closed April 3, 2023
$13.4 million in cash as of March 31, 2023
Read more at prnewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Request for Emergency Use Authorization of Niyadâ„¢ submitted to the FDA in April
Divestment of DSUVIA® to Alora Pharmaceuticals closed April 3, 2023
$13.4 million in cash as of March 31, 2023
Read more at prnewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| ACRX | 0.8600 | +0.0600 | +7.50% |
| Acelrx Pharmaceutica | |||